Services
Research and Clinical Development
Regulatory
Clinical
Biometrics
CMC
Consulting
Management Consulting
Market Access
Patient Engagement
Transaction Advisory
Lifecycle Optimization
Lifecycle Optimization
Real-World Solutions
Real-World Solutions
Biotech
Biotech
Technology
Health Storylines
A digital platform that puts patients at the center and intersection of human networks, technology, and science
b.research
A single, unified SaaS solution for all EU Phase 4, Real-World Evidence, and Post-Approval studies
RedCrow
An equity crowdfunding and crowdsourcing platform for healthcare innovation
About
Our team
Our team collaborates to fully understand every aspect of each client’s organization from concept ideation to commercial realization, from innovation to implementation
Community involvement
We work with our local and global communities to create positive change through education, service, and sustainable business practices
800+
employees
90+%
has a PhD and/or Masters
15
languages spoken
30
nationalities
Careers
Job openings
Explore our job openings and find the one that is right for you
Why work at Alira Health?
Alira Health is dedicated to providing market-leading professional development, education, travel, and work-life benefits to all team members
Join our team
Join our global team dedicated to innovation and initiative, where physical walls and different time zones don’t limit, but encourage, collaboration
Resources
News
Read all the latest from us
Blog
Insights on healthcare innovation and more
Events
Check out our upcoming events
Publications
Discover our latest industry infographics, articles, white papers, and more
Multimedia
Visit our videos, podcasts, webinars, and more.
Latest in the hub
Essential Elements of Technology Transfer
Published: September, 2023
Manufacturing Challenges of Therapeutic Antibody-Drug Conjugates
Published: September, 2023
UK HTA Approves TRANSLARNA (Ataluren) for Duchenne Muscular Dystrophy Citing Real-World Evidence
Published: September, 2023
Services
Overview
Research and Clinical Development
Regulatory Clinical Biometrics CMC
Consulting
Management Consulting Market Access Patient Engagement Transaction Advisory Lifecycle Optimization
Real-World Solutions
Real-World Solutions
Biotech
Biotech
Technology
Overview Health Storylines b.research RedCrow
About
Overview Our team Community involvement
Careers
Overview Job openings Why work at Alira Health? Join our team
Resources
Overview News Blog Events Publications Multimedia
Home > Education Hub > Opportunities and Challenges in the Therapeutic and CDMO Markets

Opportunities and Challenges in the Therapeutic and CDMO Markets

New Biologics and Advanced Therapies

The pharmaceutical market is undergoing a profound transformation, driven by innovation among biologics and advanced therapies (ATs). This shift is not only redefining the treatment landscape but also presenting new opportunities and challenges related to the drug development and manufacturing value chain.

With this backdrop, contract development and manufacturing organizations (CDMOs) play a pivotal role in enabling sponsor companies to bring groundbreaking therapies to patients.

Our Transaction Advisory experts have analyzed the CDMO industry trends, M&A activities, and projected growth. Have a look at the analysis in the article “New Biologics and Advanced Therapies: Opportunities and Challenges in the Therapeutic and CDMO Markets” published in CHEManager.

Publications
Category:
CDMO Pharma
Published on:
September 19, 2023
Read the article “New Biologics and Advanced Therapies: Opportunities and Challenges in the Therapeutic and CDMO Markets”

Want to do a deep dive into the current trends in Biologics and ATs industry? Download 2023 Biologics & Advanced Therapies Contract Manufacturing Report.

Related news

Publications September 21, 2023
Essential Elements of Technology Transfer
Peter Alexander, Senior Consultant, CMC, co-authored an article about technology transfer categories, essential elements, and documentation.
CDMO CMC
Publications September 19, 2023
Opportunities and Challenges in the Therapeutic and CDMO Markets
Our Transaction Advisory experts have analyzed the CDMO industry trends, M&A activities, and projected growth in this CHEManager article.
CDMO Pharma
Publications September 12, 2023
Global MedTech CDMO M&A Update
Discover key market insights, deal activities and their implications, and factors driving the growth and evolution of the global CDMO market.
CDMO
News August 31, 2023
Alira Health Named One of the World’s Best Management Consulting Firms by Forbes
Alira Health is proud to announce it has been named by Forbes as one of the World’s Best Management Consulting Firms for 2023.
Life Sciences MedTech Pharma
Publications August 1, 2023
The EU Pharmaceutical Package: Impact on Orphan Medicinal Products
This article reviews the proposed changes in the EU Pharma Package for data protection related to orphan medicinal products (OMPs).
EU Pharma Regulatory
Publications July 25, 2023
Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets
Our Market Access experts have identified risks and opportunities associated with improving access to medicines in emerging countries.
Market Access Pharma
Blog July 24, 2023
What EU Companies Need to Know about the U.S. Inflation Reduction Act
We spoke with our inhouse experts to learn about the significance of the US Inflation Reduction Act for EU pharma and biotech companies.
Biotech Drug Development Pharma
See all news
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.